Member Info for GlenFidrich

On 22 Jan, 2022, at 16:32, you wrote: "And here we go again. Because you don’t know exactly what’s happening that obviously means they’re either up to something, or don’t have a clue what they’re doing? Imagine being that full of your own self importance". Would you care to retract that, Gussy, old boy?

"How do thery calchulate mcap"? Thoth on the pi55 again?

In fairness, HE1 is up today!! Honestly, though, MrIndia you're in the wrong share if you're wanting immediate gains. Best to think of Hemo as a medium to long term investment. Patience is the order of the day. Don't stress the day-to-day gyrations otherwise your blood pressure will go through the roof, old thing. Keep calm, and go for long walks.

the spread? Kind of killing the action. Is it to discourage buys, or encourage sells?? I can't fathom the logic.

Chinese New Year is February 1st, 2022, the Year of the Tiger. Well, the markets are certainly taking a mauling. But is this just the Chinese equivalent of 'Black Friday' or, perhaps more precisely, 'Cyber Monday'? Just a thought. Anything in the 3p range must surely be a screaming buy?

"So many of you are expressing a desire for style over substance." Not really. Personally, I would just prefer the substance to be presented stylishly, in accordance with a company that boasts a current market cap of 141m pounds, but with aspirations (according to some on here) to be a billion pound (or more) company. If that's nauseating, feel free to puke, but you must have a very fragile constitution if that makes you sick!

A bit late if it's already in the public domain. It just makes them look like ranking amateurs, imo.

Might they (SAR) not have RNSed their participation in this, or did I miss it?
I guess the point I'm trying to make is we, the shareholders, find out about events happening courtesy of a poster on a BB/chat forum. Why is this? Another missed PR opportunity? The commercial nous - or lack thereof - is really quite breathtaking. Akin to announcing a share consolidation weeks before any EGM to discuss the matter.

Hey MrIndia, actually I'm not frustrated, I just want to highlight the psychological games that are played to persuade the uninitiated to part with their shares. It often happens just before news drops. It's actually also a good sign, as the news is likely positive. I've seen it many times before, and fell victim to it on a couple of occasions. I would simply urge investors here to read between the lines and see the MMs dropping the bid for what it is. An attempt to spook the weak hands into selling. Be careful, is all I'm saying. Just my humble opinion, each to their own, etc.

Another inconsequential UT to dull the sentiment here. Anyone would think it was a ploy to undermine confidence, or am I being cynical?

...in how to shaft shareholders. Buyers beware. I trust MW and his cronies are happy now? What goes around, comes around.

Wheeler, if the ship hasn't sailed yet, then the foghorns are blowing and the gang planks are being raised. It's been six months (and counting) since the "better than dexamethasone" claim. It seems criminal that we've seen no meaningful update since then. I didn't realize "fast tracking" was so painfully slow, but hey! Between the hare and the tortoise, who won the race? I just don't understand the apparent lack of urgency, while lives are still being lost and livelihoods are still being thrown into turmoil.

Warty, maybe the fairground that is AIM is not for you, old thing?

Sadly, the management (MW, in particular) has lost ALL TRUST. Not buying in at the current ask of 0.30p, only for those in the "inner circle" to sell at half the price, and still make money (50% minimum). They're playing the shareholders for fools. Needs to be investigated, surely?

... for repeating myself, but the OXB experience (regarding consolidation) might well be relevant here. The language used then to sell the idea of consolidation resonates here: "The Board considers the Consolidation to be in the best interests of the Company and its Shareholders. It believes that the effect of the Consolidation will be to improve market liquidity by reducing the volatility and spread of trading activity in the Company's New Consolidated Ordinary Shares and make trading in the Company's shares more attractive to a broader range of institutional investors and other members of the investing public, both overseas and in the UK." https://www.lse.co.uk/rns/OXB/proposed-share-capital-consolidation-xrvbadp9b9ihh4g.html
What's interesting is what happened next. Well, licensing deals/collaborations were announced. Lots of Directors' dealings to boot. No dilution after the consolidation, although a month prior there was a placing to raise 20m quid (yikes!). The effect on the SP (at a 50:1 consolidation)? 15p should have translated into 750p. However, the SP seems to have bottomed post-consolidation around 660p (a 12% reduction). But by a month later, the SP hit 1020p, a more than 50% increase. Thereafter, there was a decline (hastened, in no small part, by the Covid nightmare), but by September, 2021, we hit 1641p. We more than doubled in 3 years. I wouldn't be at all surprised if SAR follows the case study that is OXB - not a bad result for the LTHs amongst us? Bottom line, we all need to be patient for a while longer.

Micky, first sensible thing you've said this year (if not this decade). I appreciate other people's points of view - which is why I read these BBs. I particularly appreciate people who share their research and knowledge freely. Do I base my investment decisions on some anonymous poster's recommendation or input here? Hell no! My decision to invest here is based on my own research and therefore purely on my head, no one else's. Rampers, derampers? I couldn't care less. All I know is I'm an investor. I don't EVER short the market. I see opportunities, and I invest. For the LONG TERM. HEMO is one such investment. Enough said.

MrIndia, you keep on stating that the price is being "driven down", as if to say investors are selling in their droves. Not true, as daily volumes will confirm. If I didn't know better, I might think you were engaged in a (not-so-subtle) deramp in order to buy in cheaper yourself. Your daily belly-aching re: the direction of the SP is becoming boring. As I said before, IF you're an investor, best to turn off and return in a few weeks/months. In a way, you alighted on something when you said previously: "Also, biotech is being brutalised in the USA so not surprising small bio being battered here as well." Indeed. Therein lies the problem. The entire sector is being hammered, largely because Covid is now seen as less of a threat (erroneously, in my opinion), and because drug discovery companies are news-driven (i.e. no news = green light for the MMs to drop the bid). It was ever thus. We just need to hold, firm in the belief that the science will prevail. We are grossly undervalued - I think that much we can agree on? We just need the market to wake up, and catch up. AIMHO.

MrIndia, on December 17th the SP closed at 1.48p. On January 6th the SP stood at 2.05p. That's just shy of a 40% increase in the space of 3 weeks. There was bound to be some profit-taking from the chinless wonders that trade this stock. If you're an investor, on the other hand, these day-to-day gyrations should only be a minor irritation, surely? Moreover, the selling that is "driving the price down" (as you put it) has been pathetic in volume terms (a few million here, a few million there). It's when we see people running for the exit with volumes in the hundreds of millions that I'll become concerned. In the interim, let the science do the talking, ignore the noise, and chill out.

https://find-and-update.company-information.service.gov.uk/officers/Lrio6WXRiI-IFjuiYMirifcK0Sk/appointments
Has a few fingers in different pies.

Hi Thoth, if there is indeed "an offer waiting in the wings", might the whole consolidation proposal be linked? In other words, potential buyer/licensee tells SAR: "We're ready to do a deal, but it might be difficult to convince our shareholders of the wisdom of buying an AIM-listed penny share company. You see, the high number of shares outstanding (over 3.3 billion) and the low absolute share price might negatively affect our shareholders' perception of Sareum. A consolidation would reduce the number of shares outstanding and increase the relative price, which would then be more attractive to our shareholders, and therefore less of a hard sell". The consolidation is a means to an end, in other words.